Promotion “Targets” Needed From Sponsors Throughout Development – FDA
This article was originally published in The Tan Sheet
Executive Summary
Sponsors should provide FDA with proposed promotional claims at the start of a drug development process, the agency says in a draft guidance applicable to new drug applications
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning